IRVINE, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on
Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that CEO Simon Hubbert is scheduled to
present at the Jefferies 2016 Healthcare Conference on Wednesday, June 8, 2016, at 4:00 pm ET in New York City.
A live audio webcast may be accessed in Events and Presentations of the Investors section of Lombard’s website at www.lombardmedical.com. A webcast replay of the presentation will be available following
the conclusion of the presentation at the conference and will be archived on the Company’s website for 90 days.
About Lombard Medical, Inc.
Lombard Medical, Inc. is an Irvine, CA-based medical device company focused on the $1.7bn market for minimally invasive treatment
of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft
which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation
up to 90 degrees. The Company has also achieved CE Mark for the Altura® endograft system, an innovative
ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA
anatomies. Altura was launched in Europe in January 2016, with an international rollout planned for later in 2016. For
more information, please visit www.lombardmedical.com.
For further information: Lombard Medical, Inc. Simon Hubbert, Chief Executive Officer Tel: +1 949 379 3750 / +44 (0)1235 750 800 William J. Kullback, Chief Financial Officer Tel: +1 949 748 6764
